story of the week
An Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancreatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Independent validation and assay standardization of improved metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
Gastroenterology 2022 Jul 20;[EPub Ahead of Print], UM Mahajan, B Oehrle, S Sirtl, A Alnatsha, E Goni, I Regel, G Beyer, M Vornhülz, J Vielhauer, A Chromik, M Bahra, F Klein, W Uhl, T Fahlbusch, M Distler, J Weitz, R Grützmann, C Pilarsky, FU Weiss, G Adam, JP Neoptolemos, H Kalthoff, R Rad, N Christiansen, B Bethan, B Kamlage, MM Lerch, J MayerleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.